These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9090445

  • 21. Cyclophosphamide-induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine.
    Abdi SA, Najmi AK, Raisuddin S.
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):598-603. PubMed ID: 27234646
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and bioavailability of stereoisomeric analogues of ifosfamide.
    Sloderbach A, Hładoń B, Laskowska H.
    Acta Physiol Hung; 1996 Dec; 84(4):459-60. PubMed ID: 9328631
    [Abstract] [Full Text] [Related]

  • 23. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
    Kunze E, Köhnecke B, Engelhardt W, Steinröder H, Brock N, Pohl J.
    Urol Int; 1984 Dec; 39(2):61-7. PubMed ID: 6426112
    [Abstract] [Full Text] [Related]

  • 24. The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
    Brock N.
    Recent Results Cancer Res; 1980 Dec; 74():270-8. PubMed ID: 6777836
    [Abstract] [Full Text] [Related]

  • 25. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
    Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E.
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
    [Abstract] [Full Text] [Related]

  • 26. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Sakurai M, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Sano T, Suemasu K, Jett JR.
    Jpn J Clin Oncol; 1986 Jun; 16(2):153-6. PubMed ID: 3090314
    [Abstract] [Full Text] [Related]

  • 27. Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
    Ali SA, Danda SK, Basha SA, Rasheed A, Ahmed O, Ahmed MM.
    Indian J Pharmacol; 2014 Jun; 46(1):105-8. PubMed ID: 24550594
    [Abstract] [Full Text] [Related]

  • 28. Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner.
    Ypsilantis P, Tentes I, Assimakopoulos SF, Kortsaris A, Scopa CD, Simopoulos C.
    J Surg Res; 2004 Sep; 121(1):84-91. PubMed ID: 15313380
    [Abstract] [Full Text] [Related]

  • 29. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A, Ehrlich RM, Ljung BM.
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [Abstract] [Full Text] [Related]

  • 30. [Ifosfamide-induced urinary bladder lesion and its inhibition by mesna].
    Muraoka Y, Watanabe H, Matsui S, Nara H, Kasai H.
    Nihon Yakurigaku Zasshi; 1990 Aug; 96(2):73-83. PubMed ID: 2121633
    [Abstract] [Full Text] [Related]

  • 31. Protective effects of MESNA (2-mercaptoethane sulphonate) against acetaminophen-induced hepatorenal oxidative damage in mice.
    Sener G, Sehirli O, Cetinel S, Yeğen BG, Gedik N, Ayanoğlu-Dülger G.
    J Appl Toxicol; 2005 Aug; 25(1):20-9. PubMed ID: 15669031
    [Abstract] [Full Text] [Related]

  • 32. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP, Epelman S, Bush DA.
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
    [Abstract] [Full Text] [Related]

  • 33. Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.
    Mohrmann M, Ansorge S, Schönfeld B, Brandis M.
    Pediatr Nephrol; 1994 Aug; 8(4):458-65. PubMed ID: 7524598
    [Abstract] [Full Text] [Related]

  • 34. Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
    Araujo CE, Tessler J.
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):195-201. PubMed ID: 6402369
    [Abstract] [Full Text] [Related]

  • 35. Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
    Dornelas-Filho AF, Pereira VBM, Wong DVT, Nobre LMS, Melo AT, Silva CMS, Wanderley CWS, Nour ML, Araújo LCNC, Silva RO, Pinto FMM, Bingana RD, Souza MHLP, Alencar NMN, Silva PGB, Alves APNN, Almeida PRC, Cunha FQ, Lima-Júnior RCP.
    Int Immunopharmacol; 2018 Sep; 62():96-108. PubMed ID: 29990699
    [Abstract] [Full Text] [Related]

  • 36. The analysis of ifosfamide and its metabolites (review).
    Kaijser GP, Korst A, Beijnen JH, Bult A, Underberg WJ.
    Anticancer Res; 1993 Sep; 13(5A):1311-24. PubMed ID: 8239501
    [Abstract] [Full Text] [Related]

  • 37. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H.
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [Abstract] [Full Text] [Related]

  • 38. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.
    Korkmaz A, Topal T, Oter S.
    Cell Biol Toxicol; 2007 Sep; 23(5):303-12. PubMed ID: 17225077
    [Abstract] [Full Text] [Related]

  • 39. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM, Rankin C, Taub RN, Balcerzak SP, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.
    Cancer; 2003 Jul 15; 98(2):331-6. PubMed ID: 12872353
    [Abstract] [Full Text] [Related]

  • 40. Preservation of uroplakins by 2-mercaptoethanesulfonate in cyclophosphamide-induced rat cystitis.
    Kyung YS, Park HY, Lee G.
    Arch Toxicol; 2011 Jan 15; 85(1):51-7. PubMed ID: 20186394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.